Cystic fibrosis - elexacaftor+tezacaftor+ivacaftor - continuing authority application form (PB287)

Use this form to apply to continue PBS-subsidised treatment with elexacaftor+tezacaftor+ivacaftor for patients at least 2 years old with cystic fibrosis.

Page last updated: 1 June 2025.
QC 51932